New:
karger.com/pps/article/... . fMRI-personalised TMS for MDD: response (52%)/remission (33%), superior to open-label standard rTMS (31%/23%). RCT-acceptable (74%/53%). Response decreasing with co-morbidity (44%/ 24%) and bipolar depression or co-occurring neurological conditions (37% / 25%).
